Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The transcription factor C/EBPalpha (for CCAAT/enhancer binding protein-alpha; encoded by the gene CEBPA) is crucial for the differentiation of granulocytes. Conditional expression of C/EBPalpha triggers neutrophilic differentiation, and no mature granulocytes are observed in Cebpa-mutant mice. Here we identify heterozygous mutations in CEBPA in ten patients with acute myeloid leukemia (AML). We found that five mutations in the amino terminus truncate the full-length protein, but did not affect a 30-kD protein initiated further downstream. The mutant proteins block wild-type C/EBPalpha DNA binding and transactivation of granulocyte target genes in a dominant-negative manner, and fails to induce granulocytic differentiation. Ours is the first report of CEBPA mutations in human neoplasia, and such mutations are likely to induce the differentiation block found in AML.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We have recently shown mutations in the DNA-binding domain of C/EBP␣ in acute myeloid leukemia, suggesting its importance in granulocyte differentiation and leukemia.19”
From Granulocyte inducer C/EBPα inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions (2002) · cites this paper as [19]
Citations
Cites
The scanning model for translation: an update.
Kozak, M. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.2.229 · Cited by 3,486 · cited 1×
“These findings support the concept that CEBPA forms detected with monospecific antibodies are alternative products translated from several in-frame initiation codons by a leaky ribosome-scanning mechanis”
BackgroundThe Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding Proteins
Landschulz, W. H., Johnson, P. F., & McKnight, S. L. (1988) · Science · doi:10.1126/science.3289117 · Cited by 3,443
Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.
Cao, Z., Umek, R. M., & McKnight, S. L. (1991) · Genes & Development · doi:10.1101/gad.5.9.1538 · Cited by 1,663
Chromosomal translocations in human cancer
Rabbitts, T. H. (1994) · Nature · doi:10.1038/372143a0 · Cited by 1,503
Descombes, P., & Schibler, U. (1991) · Cell · doi:10.1016/0092-8674(91)90531-3 · Cited by 990
Isolation of a recombinant copy of the gene encoding C/EBP.
Landschulz, W. H., Johnson, P. F., Adashi, E. Y., Graves, B. J., & McKnight, S. L. (1988) · Genes & Development · doi:10.1101/gad.2.7.786 · Cited by 956
Zhang, D.-E., Zhang, P., Wang, N.-D., Hetherington, C. J., Darlington, G. J., & Tenen, D. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.569 · Cited by 910 · cited 1×
“In addition, no mature granulocytes are observed in Cebpa -mutant mice, whereas all the other blood cell types are present in normal proportion”
BackgroundSelf-citationTranscription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735 · cited 1×
“gif" NDATA ITEM> ]> Introduction A number of oncogenes that affect proliferation and cell death have been identified in leukemias and other cancers, but relatively few differentiation genes have been implicated in the malignant phenotyp”
BackgroundSelf-citationCCAAT-Enhancer Binding Protein: A Component of a Differentiation Switch
Umek, R. M., Friedman, A. D., & McKnight, S. L. (1991) · Science · doi:10.1126/science.1987644 · Cited by 712 · cited 1×
“bThe abnormalities were one del(9)(q21), one del(9)(q22q34), one t(6;9), one t(10;21)(p11;q22), one del(7)(q22q34), one +8, one +14, and four complex abnormalities.”
BackgroundRadomska, H. S., Huettner, C. S., Zhang, P., Cheng, T., Scadden, D. T., & Tenen, D. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4301 · Cited by 466 · cited 1×
“cThese patients had a 46,XY,del(12)(p11.”
Self-citation
Cited by
Items 801–900 of 930
Fröhling, S., Corbacioglu, A., Schlenk, R. F., Döhner, H., & Döhner, K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.1195 · Cited by 1
A Multi-modal LLM-Knowledge Fusion Framework for Predicting Single-cell Genetic Perturbation EffectsPreprint
Lu, M., You, N., Zhang, H., Zheng, L., Li, B., Jiang, W., Zhang, Y., Sun, H., & Zhou, Y. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.24.720560 · Cited by 1
The Role and Regulation of p21 in Myelopoiesis
Ghanem, L. R. (2005) · D-Scholarship@Pitt (University of Pittsburgh)
Anderson, M. W. (2011) · Springer eBooks · doi:10.1007/978-3-642-19677-5_18
Computational Biology in Acute Myeloid Leukemia with CEBPA Abnormalities
Taskesen, E. (2014) · EUR Research Repository (Erasmus University Rotterdam)
Studies on CEBPA mutations in acute myeloid leukaemia
Green, C. L. (2012) · UCL Discovery (University College London)
Translational Control in Myeloid Disease
Abayasekara, N., & Khanna‐Gupta, A. (2012) · InTech eBooks · doi:10.5772/34891
“…the DNA binding ability of the full length p42 C/EBP, thus inhibiting transactivation of key granulocytic target genes in a dominant-negative manner (Pabst et al., 2001), In addition, p30 transactivates the expression of a distinct subset of target genes different from that of the full length p42…”
BackgroundRegulation Of Neutrophil Homeostasis By Chemokines Signaling Through The Cxcr2 And Cxcr4 Receptors
Eash, K. J. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7js9nf7
Ortiz, A. E. (2008) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
The PI3K/PKB Signaling Module in Normal and Malignant Hematopoiesis
Polak, R., & Buitenhuis, M. (2011) · InTech eBooks · doi:10.5772/21357
“…mTOR, resulting in high levels of the smaller p30 C/EBP isoform (Fu et al., 2010) that inhibits trans-activation of C/EBP target genes in a dominant-negative manner (Pabst et al., 2001) and binds to the promoters of a unique set of target genes to suppress their transcription (Wang et al., 2007).”
The Analysis of Novel Gene Targets in Breast Cancer in Women ≤35 years
Lambe, S. M. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Prognostic and biological implications of epigenetic changes in leukemia
Deneberg, S. (2011) · Figshare
Pathophysiology of Chronic Myeloid Leukemia
Yong, A. S. M., & Melo, J. V. (2010) · Wiley eBooks · doi:10.1002/9781444327359.ch21
Sholl, L. M., & Longtine, J. A. (2010) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1004s67
“Because of the widespread distribution of described mutations in CEBPA, direct sequencing is necessary for the purposes of diagnosis; the interested reader is referred to cited references for details of primer design (Pabst et al., 2001).”
BackgroundGerin, I., Cha, H. C., & MacDougald, O. A. (2006) · Advances in molecular and cellular endocrinology · doi:10.1016/s1569-2566(06)05008-3 · Cited by 1
Santamaría-Quesada, C. (2009) · Gredos (University of Salamanca) · doi:10.14201/gredos.76292
Genomic and Epigenomic Studies of Acute Myeloid Leukemia with CEBPA Abnormalities
Wouters, B. J. (2009) · EUR Research Repository (Erasmus University Rotterdam)
Studies on Genetic Aberrations in Acute Myeloid Leukemia
Abbas, S. (2011) · EUR Research Repository (Erasmus University Rotterdam)
Neue molekulare Prognosefaktoren bei der akuten Leukämie
Baldus, C. D. (2008) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-8205
Satellite Symposia and Meet-the-Professor Sessions
Schmid, C., Schleuning, M., & Kolb, H.-J. (2006) · Annals of Hematology · doi:10.1007/s00277-005-0079-8
“Mutations in CEBP/alpha, a transcription factor regulating myeloid differentiation, have been associated with a favorable prognosis [53, 54] while altered expression of AF1q, a fusion partner in MLL gene rearrangements has been linked to poor outcomes [55] .”
BackgroundPrognostic markers in pediatric leukemia and mechanisms of KRAS induced leukemogenesis
Staffas, A. (2013) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Godoy, P. R. D. V. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2013.tde-13062013-094602
Aberrant Transcription Factors in AML
Friedman, A. D. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-322-6_2
Tailored therapeutic approaches in acute myeloid leukaemia
Käyser, S., & Schlenk, R. F. (2009) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-009-0095-9
CEBPA (CCAAT enhancer binding protein alpha)
Smith, L. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/38341
The Progress in Relationship between CCAAT/Enhancer Binding Proteins (C/EBPs) Family and Leukemia
Su, E.-Y., Bai, H., & Jiang, G. (2010) · International Conference on Bioinformatics and Biomedical Engineering · doi:10.1109/icbbe.2010.5516479
Bronchoalveolar Lavage for Diagnosis of Miliary Lung Metastases From Papillary Thyroid Carcinoma
Machens, A., & Dralle, H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.9579
Cilloni, D., Carturan, S., Maffè, C., Messa, F., Arruga, F., Messa, E., Pradotto, M., Pautasso, M., Zanone, C., Fornaciari, P., et al. (2010) · Leukemia · doi:10.1038/leu.2009.207
Ongoing Trials in Low-Grade Lymphoma
Burchardt, A. C. (2011) · Hematology Reports · doi:10.4081/hr.2011.s3.e5
Deciphering the Pathogenesis of Acute Myeloid Leukemia
Reckzeh, K. (2012) · Lund University Publications (Lund University)
Pieters, K. (2005) · Lund University Publications (Lund University)
Coskun, E. (2014) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-4237
Regulating emergency granulopoiesis
Cain, D. W. (2010) · DukeSpace (Duke University)
Valk, J. M., Melnick, A. M., Langerak, A. W., Löwenberg, B., Fazzari, M. J., Greally, J. M., Figueroa, M. E., Wouters, B. J., Skrabanek, L. A., Li, Y., et al. (2009)
Computational Biology-Driven Genomic and Epigenomic Delineation of Acute Myeloid Leukemia
Sanders, M. A. (2015) · EUR Research Repository (Erasmus University Rotterdam)
Pulikkan, J. A. (2008) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.10298
Molecular Genetic Insights in Cytogenetically-Normal Pediatric Acute Myeloid Leukemia
Hollink, I. H. I. M. (2011) · EUR Research Repository (Erasmus University Rotterdam)
Sleadd, I. M. (2000) · doi:10.15760/etd.994
“…adipocyte differentiation, hematopoiesis, liver regeneration, memory consolidation, inflammation and cancer (Darlington et al., 1998; Diehl 1998; Lekstrom-Himes and Xanthopoulos, 1998; Poli, 1998; Lane et al., 1999; Pabst et al., 2001; Ramji and Foka, 2002; Nerlov, 2007; Moore et al., 2012).”
[The expression and role of the transcription factor C/EBPα in chronic myeloid leukemia].
Zhang, G., Dong, F., Luan, C., Zhang, X., Shao, H.-Y., Liu, J., & Sun, C. (2015) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2015.11.012
the t(8;21) Fusion Protein Neurofibromatosis-1 Tumor Suppressor by Transcriptional Repression of the
Hiebert, S. W., Gutmann, D. H., Delwel, R., Clapp, D. W., Gao, M., Khalaf, W. F., & van de Locht, L. T. (2014)
New mechanisms of androgen receptor signaling
Zhang, J. (2008) · OhioLink ETD Center (Ohio Library and Information Network)
Li, Y. (2003) · ThinkTech (Texas Tech University)
Lewandowski, K. C. (2012) · Via Medica Journals
Tallman, M. S., Löwenberg, B., Bloomfield, C. D., Grimwade, D. J., Larson, R. A., Naoe, T., Niederwieser, D. W., Ossenkoppele, G. J., Sanz, M. Á., Dohner, J., et al. (2010)
Hiddemann, W. (2008)
Self-citationAus der Klinik für Hämatologie, Onkologie und Tumorimmunologie
Klinikum, C. V. (2015)
Loomis, K. D. (2008) · Europe PMC (PubMed Central)
Leukemia Stem Cells, A Pioneering Paradigmatic Model
Pearce, D. J., & Bonnet, D. A. (2007) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789812775870_0009
Studies on the core binding factor complex in patients with acute myeloid leukaemia
Langabeer, S. E. (2002) · OpenGrey (Institut de l'Information Scientifique et Technique)
Markers for Diagnosis, Prognosis, and Therapy of Acute Myeloid Leukemia
Fuchs, O. (2013) · CRC Press eBooks · doi:10.1201/b16389-34
Investigation of KLF5 Function in Normal Hematopoiesis.
Shahrin, N. H., Brown, A. L., Diakiw, S. M., & D’Andrea, R. J. (2012) · Blood · doi:10.1182/blood.v120.21.2313.2313
Kuroiwa, N., Iwase, K., Morii, S., Takiguchi, M., & Hiwasa, T. (2015) · Cited by 1
Improving leukemic CD34 + /CD38 − blasts characterization with single-cell transcriptome sequencingPreprint
Sartori, A., Cheng, P. F., Falconnet, E., Ribaux, P., Aubry-Lachainaye, J.-P., Levesque, M. P., Antonarakis, S. E., Matthes, T., & Borel, C. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/141754
Acute Myeloid Leukemias with Normal Cytogenetics
Konoplev, S. N., & Bueso-Ramos, C. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-5698-9_35
Hematopoietic Stem Cells: The Basis of Normal and Malignant Hematopoiesis
Eguchi, M., Eguchi‐Ishimae, M., & Ishii, E. (2017) · Springer eBooks · doi:10.1007/978-981-10-3886-0_1
Robetorye, R. S. (2017) · Molecular pathology library · doi:10.1007/978-3-319-62146-3_2
The Role of PU.1 in Lipid Metabolism and Cell Cycle Regulation in Myeloid Progenitor Cells
Rhee, J. (2018) · Scholarship@Western (Western University)
Novikova, S. E., Tikhonova, O. V., Kurbatov, L. K., Vakhrushev, I. V., & Zgoda, V. G. (2018) · Russian Journal of Pediatric Hematology and Oncology · doi:10.17650/2311-1267-2018-5-3-43-55
Développement d’un modèle préclinique de leucémogénèse expérimentale chez la souris humanisée
Dupont, S. (2017) · theses.fr (ABES) · doi:10.70675/3f07fe29z1659z48baz823az3d88bbcc91f4
Ahn, J., Kim, J.-Y., Kim, H., Kim, Y.-K., Lee, S.-S., Jung, S., Yang, D., Lee, J., Kim, N. Y., Choi, S. H., et al. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2563-0
The Role of Smc3 in Mouse Embryonic and Adult Hematopoiesis
Wang, T. (2019) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/z6x1-xn91
Molecular diagnostics and risk assessment in myeloid malignancies
Scharenberg, C., & Haferlach, T. (2019) · Wiley eBooks · doi:10.1002/9781119252863.ch4
NPMC+ AS A MODEL SYSTEM TO INVESTIGATE THE ROLE OF QUIESCENCE IN LEUKEMIA DEVELOPMENT
Merlo, M. E. B. (2019) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/boggio-merlo-maria-elena_phd2019-01-28
Investigation of CSF1-CSF1R Signaling in AML-Bone Marrow Stromal Cell Interactions
Rashid, A. (2019) · TSpace (University of Toronto)
Zhang, Y., Bassal, M. A., Friedrich, D., Ummarino, S., Verbiest, T., Zhang, J., Tenen, D. E., Arthanari, H., & Tenen, D. G. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.20.465166
Self-citationGene Repression and Cell Cycle Regulation by PU.1 in Acute Myeloid Leukemia
Ziliotto, R. G. (2013) · Scholarship@Western (Western University)
Grimwade, D. J., Knapper, S., & Mrózek, K. (2016) · Springer eBooks · doi:10.1007/978-3-319-19674-9_40 · Cited by 1
Exploration des proliférations myéloïdes
Béné, M. C., Aguilar‐Martinez, P., Lasne, D., Pirenne, F., Ugo, V., Fischer, A., Ajzenberg, N., Preudhomme, C., & Maynadié, M. (2018) · Elsevier eBooks · doi:10.1016/b978-2-294-75359-6.00018-4
(2007) · Science in China Series C-Life Sciences (in Chinese) · doi:10.1360/zc2007-37-2-198
(2004) · Wiley eBooks · doi:10.1002/0471684228.egp01961
Xu, J., & Jaiswal, A. K. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.a117.387738
Matiakowska, K., Bartoszewska-Kubiak, A., & Haus, O. (2022) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2022-0034
Chen, S., Yan, X., Zhou, G., & Zhu, C. H. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm011.pub2
Advances in Predisposition to Bone Marrow Failure and Hematopoietic Neoplasms
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4525-6
Molecular diagnostics and risk assessment in myeloid malignancies
Scharenberg, C., & Haferlach, T. (2024) · Wiley eBooks · doi:10.1002/9781394180486.ch4
Additional file 1 of ExplaiNN: interpretable and transparent neural networks for genomics
Novakovsky, G., Fornés, O., Saraswat, M., Mostafavi, S., & Wasserman, W. W. (2023) · Figshare · doi:10.6084/m9.figshare.23590426
Additional file 3 of ExplaiNN: interpretable and transparent neural networks for genomics
Novakovsky, G., Fornés, O., Saraswat, M., Mostafavi, S., & Wasserman, W. W. (2023) · Figshare · doi:10.6084/m9.figshare.23590432
Additional file 4 of ExplaiNN: interpretable and transparent neural networks for genomics
Novakovsky, G., Fornés, O., Saraswat, M., Mostafavi, S., & Wasserman, W. W. (2023) · Figshare · doi:10.6084/m9.figshare.23590435
Germline Predisposition to MDS and AML
Khiami, M., & Włodarski, M. W. (2024) · Pediatric oncology · doi:10.1007/978-3-031-63366-9_3
Nguyen, L. T., Zimmermann, K., Kowenz‐Leutz, E., Dörr, D., Schütz, A., Schönheit, J., Mildner, A., & Leutz, A. (2024) · iScience · doi:10.1016/j.isci.2024.111199
Aggressive Disease and Poor Clinical Outcome in CEBPα ‐Mutated Acute Myeloid Leukemia Patient
Alshammari, A. A., Alsabbagh, M., Alshehri, H. M., AlSwayyed, A. F., Alseraye, F., & Zada, A. A. P. (2025) · Clinical Case Reports · doi:10.1002/ccr3.71462
New therapeutic targets in human acute myeloid leukemia
Reikvam, H. (2012) · NVA (Nasjonalt vitenarkiv) · Cited by 1
Yun, J., Song, H., Kim, S.-M., Kim, S., Kwon, S. R., Lee, Y. E., Jeong, D., Park, J. H., Kwon, S., Yun, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26570689
Wang, L., Yao, Q., Guo, X., Wang, B., Si, J., Wang, X., Jing, S., Yan, M., Shi, Y., Song, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26743127
Additional file 2 of ExplaiNN: interpretable and transparent neural networks for genomics
Novakovsky, G., Fornés, O., Saraswat, M., Mostafavi, S., & Wasserman, W. W. (2023) · Figshare · doi:10.6084/m9.figshare.23590429
Yun, J., Song, H., Kim, S.-M., Kim, S., Kwon, S. R., Lee, Y. E., Jeong, D., Park, J. H., Kwon, S., Yun, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25458923
Yun, J., Song, H., Kim, S.-M., Kim, S., Kwon, S. R., Lee, Y. E., Jeong, D., Park, J. H., Kwon, S., Yun, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26570698
Yun, J., Song, H., Kim, S.-M., Kim, S., Kwon, S. R., Lee, Y. E., Jeong, D., Park, J. H., Kwon, S., Yun, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26570692
Yun, J., Song, H., Kim, S.-M., Kim, S., Kwon, S. R., Lee, Y. E., Jeong, D., Park, J. H., Kwon, S., Yun, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26570695
de la Torre, E. P., Serrano, J., Barragán, E., Ayala, R. M., Calasanz, M. J., Chillón, C., Soria, E., Bilbao, C., Cabello, A. I., Lavilla, E., et al. (2026) · Hematological Oncology · doi:10.1002/hon.70162
The Znf711-Phf8 complex functions as a transcriptional rheostat essential for neutrophil development
Tan, S., Qian, H., Wang, H., Chen, Y., Yuan, H., Liu, X., Wang, Y., de Thé, H., Zhu, J., & Zhou, J. (2026) · Haematologica · doi:10.3324/haematol.2025.300134
Cholesterol Biosynthesis is a Targetable Vulnerability of CEBPA -mutant Acute Myeloid LeukemiaPreprint
Schovsbo, S. U., Liu, Y., Aragon-Fernandez, P., Gordon, S. L., Schuster, M. B., Su, J., Pundhir, S., Mikkelsen, N. S., Schoof, E. M., Theilgaard‐Mönch, K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.20.706425
Metadata
- Authors
- Pabst, T., Mueller, B. U., Zhang, P., Radomska, H. S., Narravula, S., Schnittger, S., Behre, G., Hiddemann, W., & Tenen, D. G.
- Affiliations
- Harvard University (US)
- Ludwig-Maximilians-Universität München (DE)
- Corresponding author
- Tenen, Daniel G.
- Venue
- Nature Genetics
- Published
- 2001-03
- Volume
- 27
- Issue
- 3
- Pages
- 263-270
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2100088478
- Cited by
- 901
- References
- 33
- Citations by year
- 2026: 15 · 2025: 11 · 2024: 23 · 2023: 21 · 2022: 30 · 2021: 22 · 2020: 27 · 2019: 17 · 2018: 22 · 2017: 27 · 2016: 29 · 2015: 47 · 2014: 37 · 2013: 34 · 2012: 50
- FWCI
- 23.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL056745, HL56745)
- National Cancer Institute (CA-72009, P01CA072009)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- CEBPA, C/EBPα, acute myeloid leukemia, dominant negative mutation, heterozygous mutation, transcription factors, granulocytic differentiation, DNA binding, transcriptional activation, N-terminal truncation
- MeSH terms
- Base Sequence, Cell Differentiation, Cell Nucleus, DNA, Neoplasm, Genes, Dominant, Granulocytes, Heterozygote, Humans, Mutation, Neutrophils, Leukemia, Myeloid, Acute, Transcriptional Activation, Sequence Deletion, DNA Primers, CCAAT-Enhancer-Binding Protein-alpha, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.